TSH DÜZEYİ NORMAL, DÜŞÜK VE YÜKSEK HASTALARDA VÜCUT KİTLE İNDEKSLERİNE GÖRE HDL DÜZEYLERİNİN KARŞILAŞTIRILMASI

Amaç Obezite dünyada prevelansı gittikçe artan bir sağlık problemidir. Obezite ayrıca dislipideminin önemli nedenlerinden biridir Son yıllarda tiroid hormon düzeyleri ve vücut kitle indekslerini (VKİ) karşılaştıran pek çok çalışma vardır. Ayrıca tiroid hormon testleri ve lipid profilini inceleyen çalışmalarda mevcuttur. Bu çalışmanın amacı, erişkin bireylerde Tiroid Stimulan Hormon (TSH) düzeyleri normal, düşük ya da yüksek olmasının vücut kitle indeksine göre Yüksek Dansiteli Lipoprotein (HDL) düzeylerine etkisinin değerlendirilmesidir. Gereç ve Yöntem Çalışma retrospektif olarak veri analiz yöntemiyle dizayn edildi. Aralık 2016- Eylül 2020 tarihleri arasında özel bir üniversite hastanesinin Checkup polikliniğine başvurmuş; Herhangi bir tiroid ilacı kullanmayan, TSH, VKİ, HDL değerleri bakılmış, 18 yaş üstü bireylerin verileri toplandı(n=1621). Sosyo-demografik veri olarak ayrıca her hasta için yaş ve cinsiyet verileri de kaydedildi. Veriler SPSS 25.0 paket programıyla analiz edildi. Sürekli değişkenler ortalama ± standart sapma ve ortanca (min, maks), kategorik değişkenler ise sayı ve yüzde olarak ifade edildi. Verilerin normal dağılıma uygunluğu Kolmogorov Smirnov testi ve histogramlar ile incelendi. Bağımsız grup incelemelerinde; Mann Whitney U testi ve Kruskal Wallis Varyans Analizi (post hoc: Bonferroni düzeltmeli Mann Whitney U testi) kullanıldı. Kategorik değişkenler arasındaki farklılıkların incelenmesinde ise Ki kare testi kullanıldı. Tüm analizlerde p0,05). Sonuç Çalışmamızda normal kilolu olan kişiler arasında TSH değeri normal olanların HDL değerleri, TSH değeri yüksek olanlara göre anlamlı şekilde düşük bulundu. Bu konuda hem erişkin hem çocuklarda yapılan bazı çalışmalar olsa da hala araştırmaya açık bir konudur. Bu alanda yapılacak yeni çalışmalar ile konu hakkında daha ayrıntılı ilişkiler saptanabilecektir.

COMPARISON OF HDL LEVELS ACCORDING TO BODY MASS INDEXES IN PATIENTS WITH NORMAL, LOW AND HIGH TSH LEVELS

Objective The prevalence of obesity is an increasing health problem throughout the world. Obesity is also one of the major causes of dyslipidemia. There have been many studies comparing thyroid hormone levels and body mass indexes (BMI) in recent years. There are also studies available in thyroid hormone tests and studies examining lipid profile. The aim of this study is to evaluate the effect of normal, low or high Thyroid Stimulated Hormone (TSH) levels on High Density Lipoprotein (HDL) levels according to body mass index in adult individuals. Material and Methods The study was retrospectively designed with data analysis method. The study was applied in the private university hospital Checkup clinic between December 2016 and September 2020; TSH, VKİ, HDL values were studied, and data of individuals over 18 years of age were collected (n=1621). As sociodemographic data, age and gender data were also recorded for each patient. Data was analyzed via SPSS 25.0 package program. Continuous variables are expressed as mean ± standard deviation and median (min, max), and categorical variables are expressed as numbers and percentages. Kolmogorov Smirnov Smirnov test and histograms was used to examine compliance of data to normal distribution. In independent group reviews Mann Whitney U test and Kruskal Wallis Variance Analysis (post hoc: Mann Whitney U test with Bonferroni correction) were used. In the examination of the differences between categorical variables, the Ki square test was used. All analysis P0.05). Conclusion In our study, HDL values of normal people with normal TSH value were found to be significantly lower than those with high TSH values among people who were normal weight. Although there are some studies in both adults and children, it is still open to research. It would be possible to detect more detailed relationships on the subject with new studies to be carried out in this field.

PDF

___

1. Obesity and overweight. Available at: https://www.who.int/ news-room/fact-sheets/detail/obesity-and-overweight. Erişim tarihi: 23.09.2021
2. OECD Health Statistics 2014. Available at: https://www.oecd. org/els/health-systems/oecd-health-statistics-2014-frequently-requested-data. Erişim tarihi: 23.09.2021
3. İslamoğlu Y, Koplay M, Sunay S ve ark. Obezite ve Metabolik Sendrom. Tıp Araştırmaları Dergisi. 2008; 6: 3.
4. Carantoni M, Vigna GB, Stucci N, et al. Low Levels of HDL Cholesterol in Hypothyroid Patients with Cardiovascular Diseases. Minerva Endocrinol. 1997; 22(4): 91-7.
5. Reinehr T, Andler W, Denzer C, et al. Cardiovascular Risk Factors in Overweight German Children and Adolescents: Relation to Gender, Age and Degree of Overweight. Nutrition, Metabolism and Cardiovascular Diseases. 2005; 15(3): 181-187.
6. Burke V, Beilin LJ, Simmer K, et al. Predictors of Body Mass Index and Associations with Cardiovascular Risk Factors in Australian Children: A Prospective Cohort Study. İnternational Journal of Obesity. 2005; 29(1): 15-23.
7. Ekinci F, Coşkun DM, Tuncel B ve ark. Relationship between Obesity and Thyroid Function in Adults. Marmara Medical Journal. 2018; 31: 76-80.
8. Buscemi S, Verga S, Maneri R, et al. İnfluences of Obesity and Weight Loss on Thyroid Hormones. A 3–3.5- Year Follow- Up Study on Obese Subjects With Surgical Bilio-Pancreatic Bypass. J Endocrinol İnvest. 1997; 20: 276-81.
9. Manji N, Boelaert K, Sheppard MC, et al. Lack of Association Between Serum TSH or Free T4 and Body Mass İndex in Euthyroid Subjects. Clin Endocrinol. 2006; 64: 125-8.
10. Altunoğlu E, Ülgen E, Müderrisoğlu C ve ark. Obezite ve Tiroid Fonksiyonları. İstanbul Tıp Dergisi. 2009; 1: 24-5.
11. Shinkov A, Borissova AM, Kovatcheva R, et al. The Prevalence of the Metabolic Syndrome Increases through The Quartiles of Thyroid Stimulating Hormone in A Population-Based Sample of Euthyroid Subjects. Arq Bras Endocrinol Metabol. 2014; 58: 926-32.
12. Lagrost L. Regulation of Cholesteryl Ester Transfer Protein (CETP) Activity: Review of invitro and invivo Studies. Biochim Biophys Acta. 1994; 1215:209–36.
13. Pearce EN, Wilson WF, Yang Q, et al. Thyroid Function and Lipid Subparticle Sizes in Patients with Short-Term Hypothyroidism and a Population-Based Cohort. J Clin Endocrinol Metab, 2008; 93: 888–94.
14. Lam KS, Chan MK, Yeung RT. High-density Lipoprotein Cholesterol, Hepatic Lipase and Lipoprotein Lipase Activities in Thyroid Dysfunction-Effects of Treatment. QJ Med. 1986; 59: 513–21.
15. Dullaart RP, Hoogenberg K, Groener JE, et al. The Activity of Cholesteryl Ester Transfer Protein is Decreased in Hypothyroidism: A Possible Contribution to Alterations in High-Density Lipoproteins. Eur J Clin İnvest. 1990; 20: 581-7.
16. Duntas LH. Thyroid Disease and Lipids. Thyroid Journal. 2002; 12(4): 287-93.
17. Asvold BO, Vatten LJ,Nilsen IL, et al; The Association Between TSH Within the Reference Range and Serum Lipid Concentrations in a Population-Based Study. The HUNT Study. Eur J Endocrinol. 2007; 156: 181–6.
18. Kung AW, Pang RW, Lauder I, et al. Changes in Serum Lipoprotein(a) and Lipids During Treatment of Hyperthyroidism. Clin Chem. 1995; 41: 226–31.
19. Aviram M, Luboshitzky R, Brook JG. Lipid and Lipoprotein Pattern in Thyroid Dysfunction and the Effect of Therapy. Clin Biochem. 1982; 15: 62–6.